Suppr超能文献

聚乙二醇链长对伊曲康唑在聚乙二醇/羟丙基甲基纤维素2910 E5共混物中三元固体分散体的相容性和释放特性的影响。

Influence of polyethylene glycol chain length on compatibility and release characteristics of ternary solid dispersions of itraconazole in polyethylene glycol/hydroxypropylmethylcellulose 2910 E5 blends.

作者信息

Janssens Sandrien, Denivelle Samgar, Rombaut Patrick, Van den Mooter Guy

机构信息

Laboratorium voor Farmacotechnologie en Biofarmacie, University of Leuven, Herestraat 49 b921, Leuven, Belgium.

出版信息

Eur J Pharm Sci. 2008 Oct 2;35(3):203-10. doi: 10.1016/j.ejps.2008.06.014. Epub 2008 Jul 5.

Abstract

The present study aims to elucidate the influence of the polyethylene glycol chain length on the miscibility of PEG/HPMC 2910 E5 polymer blends, the influence of polymer compatibility on the degree of molecular dispersion of itraconazole, and in vitro dissolution. PEG 2000, 6000, 10,000 and 20,000 were included in the study. Solid dispersions were prepared by spray drying and characterized with MDSC, XRPD and in vitro dissolution testing. The polymer miscibility increased with decreasing chain length due to a decrease in the Gibbs free energy of mixing. Recrystallization of itraconazole occurred as soon as a critical temperature of ca. 75 degrees C was reached for the glass transition that represents the ternary amorphous phase. Due to the lower miscibility degree between the longer PEG types and HPMC 2910 E5, the ternary amorphous phase was further separated, leading to a more rapid decrease of the ternary amorphous phase glass transition as a function of PEG and itraconazole weight percentage and hence, itraconazole recrystallization. In terms of release, an advantage of the shorter chain length PEG types (2000, 6000) over the longer chain length PEG types (10,000, 20,000) was observed for the polymer blends with 5% of PEG with respect to the binary itraconazole/HPMC 2910 E5 solid dispersion. Among the formulations with a 15/85 (w/w) PEG/HPMC 2910 E5 ratio on the other hand, there was no difference in the release profile.

摘要

本研究旨在阐明聚乙二醇链长对PEG/HPMC 2910 E5聚合物共混物混溶性的影响、聚合物相容性对伊曲康唑分子分散程度的影响以及体外溶出度。研究中纳入了PEG 2000、6000、10000和20000。通过喷雾干燥制备固体分散体,并采用MDSC、XRPD和体外溶出度测试对其进行表征。由于混合吉布斯自由能降低,聚合物混溶性随链长减小而增加。一旦达到约75摄氏度的临界温度,即代表三元无定形相的玻璃化转变温度,伊曲康唑就会发生重结晶。由于较长链PEG类型与HPMC 2910 E5之间的混溶性较低,三元无定形相进一步分离,导致三元无定形相玻璃化转变随PEG和伊曲康唑重量百分比的变化而更快降低,从而导致伊曲康唑重结晶。在释放方面,对于含5%PEG的聚合物共混物相对于二元伊曲康唑/HPMC 2910 E5固体分散体,观察到较短链长PEG类型(2000、6000)比长链长PEG类型(10000、20000)具有优势。另一方面,在PEG/HPMC 2910 E5比例为15/85(w/w)的制剂中,释放曲线没有差异。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验